Bladder cancer "adjuvant-lite": Tastes great (works as well) and less filling (less toxic)?

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 4823-4826

  Galsky, Matthew D ^a   Scher, Howard I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; ANTINEOPLASTIC AGENT; EPIRUBICIN; M VEC PROTOCOL; M-VEC PROTOCOL; VINBLASTINE;

ADJUVANT THERAPY; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CYSTECTOMY; DEATH; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; FEBRILE NEUTROPENIA; HEARING LOSS; HUMAN; KIDNEY DISEASE; METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; BLADDER TUMOR; DOSE RESPONSE; NOTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; HUMANS; METHOTREXATE; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 24644492916     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.92.001     Document Type: Editorial

References (18)

1. Lehmann J, Retz M, Wiemers C, et al: Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: Results of a randomized, multicenter, phase III trial J Clin Oncol 23:4963-4974, 2005
2. Loehrer PJ Sr, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 10:1066-1073, 1992
3. Logothetis CJ, Dexeus F, Sella A, et al: A prospective randomized trial comparing CISCA to MVAC chemotherapy in advanced metastatic urothelial tumors. J Clin Oncol 8:1050-1055, 1990
4. Mead GM, Russell M, Clark P, et al: A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: Results and a report on prognostic factors in a Medical Research Council study-MRC Advanced Bladder Cancer Working Party. Br J Cancer 78:1067-1075, 1998
5. International Collaboration of Trialists: Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial-International collaboration of trialists. Lancet 354:533-540, 1999
6. Hall R: Updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. Proc Am Soc Clin Oncol 21:178a, 2002 (abstr 710)
7. Grossman HB, Natale RB, Tangen CM, et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866, 2003
8. Bono AV, Benvenuti C, Reali L, et al: Adjuvant chemotherapy in advanced bladder cancer: Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res 303:533-540, 1989
9. Stockle M, Meyenburg W, Wellek S, et al: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy-Results of a controlled prospective study. J Urol 148:302-306, 1992
10. Skinner DG, Daniels JR, Russell CA, et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 145:459-464, 1991
11. Studer UE, Bacchi M, Biedermann C, et al: Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol 152:81-84, 1994
12. Freiha F, Reese J, Torti FM: A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 55:495-499, 1996
13. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998
14. Millikan R, Dinney C, Swanson D, et al: Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19:4005-4013, 2001
15. von der Maase H, Hansen SW, Roberts JT, et al: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068-3077, 2000
16. Hillcoat BL, Raghavan D, Matthews J, et al: A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. J Clin Oncol 7:706-709, 1989
17. Advanced Bladder Cancer Meta-Analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet 361:1927-1934, 2003
18. Bajorin DF: Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. J Clin Oncol 19:17S-20S, 2001 (suppl 18)